Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma

被引:5
|
作者
Zhai, Wenyu [1 ]
Liang, Dachuan [1 ]
Duan, Fangfang [2 ]
Wong, Wingshing [1 ]
Yan, Qihang [3 ]
Gong, Li [1 ]
Lai, Renchun [4 ]
Dai, Shuqin [5 ]
Long, Hao [1 ]
Wang, Junye [1 ]
机构
[1] Sun Yat Sen Univ, Dept Thorac Surg, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Dept Med Oncol, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
[3] Zhejiang Univ, Dept Thorac Surg, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China
[4] Sun Yat Sen Univ, Dept Anaesthesiol, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Dept Lab Med, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
关键词
lung adenocarcinoma; pathological subtype; GGO (ground glass opacity); nomogram; prognosis; PREDOMINANT HISTOLOGIC SUBTYPE; FACTOR RECEPTOR MUTATION; EGFR MUTATION; INTERNATIONAL ASSOCIATION; FREE SURVIVAL; CLASSIFICATION; CANCER; MICROPAPILLARY; IMPACT; CT;
D O I
10.3389/fcell.2021.769881
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The value of lung adenocarcinoma (LUAD) subtypes and ground glass opacity (GGO) in pathological stage IA invasive adenocarcinoma (IAC) has been poorly understood, and reports of their association with each other have been limited. In the current study, we retrospectively reviewed 484 patients with pathological stage IA invasive adenocarcinoma (IAC) at Sun Yat-sen University Cancer Center from March 2011 to August 2018. Patients with at least 5% solid or micropapillary presence were categorized as high-risk subtypes. Independent indicators for disease-free survival (DFS) and overall survival (OS) were identified by multivariate Cox regression analysis. Based on these indicators, we developed prognostic nomograms of OS and DFS. The predictive performance of the two nomograms were assessed by calibration plots. A total of 412 patients were recognized as having the low-risk subtype, and 359 patients had a GGO. Patients with the low-risk subtype had a high rate of GGO nodules (p < 0.001). Multivariate Cox regression analysis showed that the high-risk subtype and GGO components were independent prognostic factors for OS (LUAD subtype: p = 0.002; HR 3.624; 95% CI 1.263-10.397; GGO component: p = 0.001; HR 3.186; 95% CI 1.155-8.792) and DFS (LUAD subtype: p = 0.001; HR 2.284; 95% CI 1.448-5.509; GGO component: p = 0.003; HR 1.877; 95% CI 1.013-3.476). The C-indices of the nomogram based on the LUAD subtype and GGO components to predict OS and DFS were 0.866 (95% CI 0.841-0.891) and 0.667 (95% CI 0.586-0.748), respectively. Therefore, the high-risk subtype and GGO components were potential prognostic biomarkers for patients with stage IA IAC, and prognostic models based on these indicators showed good predictive performance and satisfactory agreement between observational and predicted survival.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The Histologic Subtype of Lung Adenocarcinoma Should Not Deter Sublobar Resection for Patients with Clinical Stage IA Lung Cancer
    Kamel, Mohamed
    Narula, Navneet
    Stiles, Brendon
    Nasar, Abu
    Ghaly, Galal
    Rahouma, Mohamed
    Port, Jeffery
    Lee, Paul
    Paul, Subroto
    Altorki, Nasser
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S432 - S433
  • [32] Prognostic value of ground glass opacity on computed tomography in pathological stage I pulmonary adenocarcinoma: A meta -analysis
    Pan, Xue-Lin
    Liao, Zi-Ling
    Yao, Hui
    Yan, Wei-Jie
    Wen, De-Ying
    Wang, Yan
    Li, Zhen-Lin
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (33) : 10222 - 10232
  • [33] Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma
    Jeon, Hyun Woo
    Kim, Young-Du
    Sim, Sung Bo
    Moon, Mi Hyoung
    THORACIC CANCER, 2021, 12 (14) : 2072 - 2077
  • [34] Pathological prognostic factors of recurrence in early stage lung adenocarcinoma
    Yi, Eunjue
    Bae, Mi-Kyeong
    Cho, Sukki
    Chung, Jin-Haeng
    Jheon, Sanghoon
    Kim, Kwhanmien
    ANZ JOURNAL OF SURGERY, 2018, 88 (04) : 327 - 331
  • [35] Nomograms for intraoperative prediction of lymph node metastasis in clinical stage IA lung adenocarcinoma
    Li, Feng
    Zhai, Suokai
    Fu, Li
    Yang, Lin
    Mao, Yousheng
    CANCER MEDICINE, 2023, 12 (13): : 14360 - 14374
  • [36] Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma
    Tsubokawa, Norifumi
    Mimae, Takahiro
    Sasada, Shinsuke
    Yoshiya, Tomoharu
    Mimura, Takeshi
    Murakami, Shuji
    Ito, Hiroyuki
    Miyata, Yoshihiro
    Nakayama, Haruhiko
    Okada, Morihito
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (01) : 293 - 299
  • [37] Prognostic significance of micropapillary and solid patterns in stage IA lung adenocarcinoma
    Peng, Bin
    Li, Guofeng
    Guo, Yanhua
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 10562 - 10569
  • [38] Mitotic count is not a significant prognostic factor in stage Ia lung adenocarcinoma
    Zombori, T.
    Nemedi, R.
    Urban, D.
    Furak, J.
    Tiszlavicz, L.
    VIRCHOWS ARCHIV, 2016, 469 : S328 - S329
  • [39] Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma
    Zhang, Jie
    Shao, Jinchen
    Zhu, Lei
    Zhao, Ruiying
    Xing, Jie
    Wang, Jun
    Guo, Xiaohui
    Tu, Shichun
    Han, Baohui
    Yu, Keke
    ONCOTARGET, 2017, 8 (43) : 74846 - 74855
  • [40] Clinical Features and Surgical Outcomes of Young Patients with Ground Glass Opacity Featured Lung Adenocarcinoma
    Qu, R.
    Fu, X.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S176 - S177